The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

American Heart Association

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of American Heart Association

 

Psychiatry related information on American Heart Association

 

High impact information on American Heart Association

  • In a randomized, double-blind, placebo-controlled trial, we studied coronary endothelial responses in 23 patients randomly assigned to either lovastatin (40 mg twice daily; 11 patients) or placebo (12 patients) plus a lipid-lowering diet (American Heart Association Step 1 diet) [8].
  • PARTICIPANTS--Representatives from the Society for Academic Emergency Medicine and the American Heart Association identified several professional organizations as stakeholders in this issue, including research, clinical, bioethics, legal, and patient advocacy groups [9].
  • Is the AHA/ACSM Scientific Statement "Recommendations for Cardiovascular Screening, Staffing, and Emergency Policies at Health/Fitness Facilities" in need of revision? American Heart Association. American College of Sports Medicine [10].
  • Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association [11].
  • Our investigation paralleled the elaboration of the American College of Cardiology/ American Heart Association (ACC/AHA) Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery and is highly comparable to the proposed guidelines [12].
 

Chemical compound and disease context of American Heart Association

 

Biological context of American Heart Association

 

Anatomical context of American Heart Association

 

Associations of American Heart Association with chemical compounds

 

Gene context of American Heart Association

 

Analytical, diagnostic and therapeutic context of American Heart Association

References

  1. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Stiell, I.G., Hébert, P.C., Wells, G.A., Vandemheen, K.L., Tang, A.S., Higginson, L.A., Dreyer, J.F., Clement, C., Battram, E., Watpool, I., Mason, S., Klassen, T., Weitzman, B.N. Lancet (2001) [Pubmed]
  2. Recreational and occupational recommendations for young patients with heart disease. A Statement for Physicians by the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. Gutgesell, H.P., Gessner, I.H., Vetter, V.L., Yabek, S.M., Norton, J.B. Circulation (1986) [Pubmed]
  3. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Grundy, S.M., Balady, G.J., Criqui, M.H., Fletcher, G., Greenland, P., Hiratzka, L.F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H.M., LaRosa, J., Ockene, I.S., Pearson, T.A., Reed, J., Washington, R., Smith, S.C. Circulation (1998) [Pubmed]
  4. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Roubin, G.S., Cannon, A.D., Agrawal, S.K., Macander, P.J., Dean, L.S., Baxley, W.A., Breland, J. Circulation (1992) [Pubmed]
  5. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Maron, B.J., Thompson, P.D., Puffer, J.C., McGrew, C.A., Strong, W.B., Douglas, P.S., Clark, L.T., Mitten, M.J., Crawford, M.H., Atkins, D.L., Driscoll, D.J., Epstein, A.E. Circulation (1996) [Pubmed]
  6. Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects. Keenan, J.M., Wenz, J.B., Myers, S., Ripsin, C., Huang, Z.Q. The Journal of family practice. (1991) [Pubmed]
  7. Exercise and heart disease in women: why, how, and how much? Glassberg, H., Balady, G.J. Cardiology in review. (1999) [Pubmed]
  8. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure, C.B., Klein, J.L., Weintraub, W.S., Talley, J.D., Stillabower, M.E., Kosinski, A.S., Zhang, J., Boccuzzi, S.J., Cedarholm, J.C., Alexander, R.W. N. Engl. J. Med. (1995) [Pubmed]
  9. Informed consent in emergency research. Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. Biros, M.H., Lewis, R.J., Olson, C.M., Runge, J.W., Cummins, R.O., Fost, N. JAMA (1995) [Pubmed]
  10. Is the AHA/ACSM Scientific Statement "Recommendations for Cardiovascular Screening, Staffing, and Emergency Policies at Health/Fitness Facilities" in need of revision? American Heart Association. American College of Sports Medicine. Cardinal, B.J. Circulation (1999) [Pubmed]
  11. Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association. Maron, B.J., Thompson, P.D., Puffer, J.C., McGrew, C.A., Strong, W.B., Douglas, P.S., Clark, L.T., Mitten, M.J., Crawford, M.D., Atkins, D.L., Driscoll, D.J., Epstein, A.E. Circulation (1998) [Pubmed]
  12. Cardiac risk stratification for high-risk vascular surgery. Bartels, C., Bechtel, J.F., Hossmann, V., Horsch, S. Circulation (1997) [Pubmed]
  13. C-reactive Protein. Black, S., Kushner, I., Samols, D. J. Biol. Chem. (2004) [Pubmed]
  14. Bacteremia in patients undergoing oral procedures. Study following parenteral antimicrobial prophylaxis as recommended by the American Heart Association, 1977. Baltch, A.L., Pressman, H.L., Schaffer, C., Smith, R.P., Hammer, M.C., Shayegani, M., Michelsen, P. Arch. Intern. Med. (1988) [Pubmed]
  15. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Nesto, R.W., Bell, D., Bonow, R.O., Fonseca, V., Grundy, S.M., Horton, E.S., Le Winter, M., Porte, D., Semenkovich, C.F., Smith, S., Young, L.H., Kahn, R. Diabetes Care (2004) [Pubmed]
  16. Gram-negative endocarditis following cystoscopy. Marier, R., Valenti, A.J., Mardi, J.A. J. Urol. (1978) [Pubmed]
  17. Four case studies: high-dose epinephrine in cardiac arrest. Martin, D., Werman, H.A., Brown, C.G. Annals of emergency medicine. (1990) [Pubmed]
  18. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., Criqui, M., Fadl, Y.Y., Fortmann, S.P., Hong, Y., Myers, G.L., Rifai, N., Smith, S.C., Taubert, K., Tracy, R.P., Vinicor, F. Circulation (2003) [Pubmed]
  19. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Brook, R.D., Franklin, B., Cascio, W., Hong, Y., Howard, G., Lipsett, M., Luepker, R., Mittleman, M., Samet, J., Smith, S.C., Tager, I. Circulation (2004) [Pubmed]
  20. Dietary treatment of hypercholesterolemia. Friedman, B.J., Amos, T., Goldman, D. Texas medicine. (1990) [Pubmed]
  21. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Pickering, T.G., Hall, J.E., Appel, L.J., Falkner, B.E., Graves, J., Hill, M.N., Jones, D.W., Kurtz, T., Sheps, S.G., Roccella, E.J. Hypertension (2005) [Pubmed]
  22. Stroke and women. Bader, M.K., Prendergast, V. Critical care nursing clinics of North America. (1997) [Pubmed]
  23. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? Sundt, T.M., Zehr, K.J., Dearani, J.A., Daly, R.C., Mullany, C.J., McGregor, C.G., Puga, F.J., Orszulak, T.A., Schaff, H.V. J. Thorac. Cardiovasc. Surg. (2005) [Pubmed]
  24. Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures. Kirtane, A.J., Rahman, A.M., Martinezclark, P., Jeremias, A., Seto, T.B., Manning, W.J. Am. J. Cardiol. (2006) [Pubmed]
  25. The application of official policy. Prophylaxis recommendations for patients with mitral valve prolapse. Retchin, S.M., Fletcher, R.H., Buescher, P.C., Waugh, R.A., Battaglini, S.W. Medical care. (1985) [Pubmed]
  26. Experimental rupture of atherosclerotic lesions increases distal vascular resistance: a limiting factor to the success of infarct angioplasty. Taylor, A.J., Bobik, A., Berndt, M.C., Ramsay, D., Jennings, G. Arterioscler. Thromb. Vasc. Biol. (2002) [Pubmed]
  27. Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet or a Step 1 diet with added monounsaturated fat. Ginsberg, H.N., Barr, S.L., Gilbert, A., Karmally, W., Deckelbaum, R., Kaplan, K., Ramakrishnan, R., Holleran, S., Dell, R.B. N. Engl. J. Med. (1990) [Pubmed]
  28. Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. Hirsh, J., Fuster, V. Circulation (1994) [Pubmed]
  29. Report of the Expert Panel on Awareness and Behavior Change to the Board of Directors, American Heart Association. Carleton, R.A., Bazzarre, T., Drake, J., Dunn, A., Fisher, E.B., Grundy, S.M., Hayman, L., Hill, M.N., Maibach, E.W., Prochaska, J., Schmid, T., Smith, S.C., Susser, M.W., Worden, J.W. Circulation (1996) [Pubmed]
  30. Value and safety of diet modification to control hyperlipidemia in childhood and adolescence. A statement for physicians. Ad Hoc Committee of the Steering Committee for Medical and Community Program of the American Heart Association. Glueck, C.J., McGill, H.C., Shank, R.E., Lauer, R.M. Circulation (1978) [Pubmed]
  31. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Hirsh, J., Fuster, V., Ansell, J., Halperin, J.L. J. Am. Coll. Cardiol. (2003) [Pubmed]
  32. Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Laskey, W.K., Williams, D.O., Vlachos, H.A., Cohen, H., Holmes, D.R., King, S.B., Kelsey, S.F., Slater, J., Faxon, D., Al-Bassam, M., Block, E., Detre, K.M. Am. J. Cardiol. (2001) [Pubmed]
  33. Keeping American Heart Association ACLS standards and guidelines current. Ornato, J.P., Kerber, R.E. Annals of emergency medicine. (1991) [Pubmed]
  34. Gene therapy with vascular endothelial growth factor reduces angina. Merkle, C.J., Montgomery, D.W. The Journal of cardiovascular nursing. (2003) [Pubmed]
  35. The clinical lipid specialist. Task Force on Cholesterol Issues, American Heart Association. LaRosa, J.C. Circulation (1990) [Pubmed]
  36. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Tricoci, P., Roe, M.T., Mulgund, J., Newby, L.K., Smith, S.C., Pollack, C.V., Fintel, D.J., Cannon, C.P., Bhatt, D.L., Gibler, W.B., Ohman, E.M., Peterson, E.D., Harrington, R.A. Arch. Intern. Med. (2006) [Pubmed]
  37. Report of the American Heart Association Task Force on the Future of Cardiopulmonary Resuscitation. Cobb, L.A., Eliastam, M., Kerber, R.E., Melker, R., Moss, A.J., Newell, L., Paraskos, J.A., Weaver, W.D., Weil, M., Weisfeldt, M.L. Circulation (1992) [Pubmed]
  38. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Breithardt, G., Cain, M.E., el-Sherif, N., Flowers, N.C., Hombach, V., Janse, M., Simson, M.B., Steinbeck, G. Circulation (1991) [Pubmed]
  39. Guidelines for pediatric therapeutic cardiac catheterization. A statement for health professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, the American Heart Association. Allen, H.D., Driscoll, D.J., Fricker, F.J., Herndon, P., Mullins, C.E., Snider, A.R., Taubert, K.A. Circulation (1991) [Pubmed]
  40. Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart Association guidelines. Kilaru, P.K., Kelly, R.F., Calvin, J.E., Parrillo, J.E. J. Am. Coll. Cardiol. (2000) [Pubmed]
  41. Risk stratification after successful coronary revascularization: the lack of a role for routine exercise testing. Krone, R.J., Hardison, R.M., Chaitman, B.R., Gibbons, R.J., Sopko, G., Bach, R., Detre, K.M. J. Am. Coll. Cardiol. (2001) [Pubmed]
 
WikiGenes - Universities